How should healthcare organisations govern employee use of GenAI when sensitive patient data may be pasted into public tools?

How healthcare GenAI governance should work in practice

For healthcare, the core governance mistake is treating GenAI like a generic acceptable-use issue. The control objective is narrower and more operational: prevent protected health information from being pasted into public tools, while still allowing approved use cases that do not expose patient data. That means the policy must be backed by NIST AI 600-1 Generative AI Profile style governance, where teams define where GenAI is allowed, what data classes are forbidden, and how exceptions are reviewed.

Real governance also needs data classification that is understandable at the point of use. Staff should not have to interpret a legal definition in the middle of a clinical or administrative task. The practical standard is to make the boundary easy to recognise, then pair it with controls that can block or sanitize high-risk text before submission. That is closer to an information protection problem than a training-only problem.

When the organisation is using enterprise AI services or internal copilots, the governance bar should include logging, approval of sanctioned tools, and clear retention rules for prompts and outputs. For broader organisational control, NIST Cybersecurity Framework 2.0 helps structure the program around govern, protect, detect, respond, and recover, which fits this problem well because the issue spans policy, detection, and response rather than only one control family.

Why visibility and sanitisation matter more than punishment

A policy that only says “do not paste patient data into GenAI” is weak because it depends on memory, judgement, and perfect compliance. In real operations, staff will use whichever tool is easiest, especially if they are trying to draft summaries, letters, codes, or explanations quickly. The effective control is to see the event as it happens and either stop it or remove sensitive content before transmission.

That visibility has to be tuned for healthcare data patterns, not just generic personally identifiable information. Free-text notes, lab values, medication histories, appointment details, and identifiers can all create privacy exposure even when the prompt does not look obviously sensitive. Current guidance suggests organisations should combine DLP-style inspection with redaction and user-facing warnings, because the best outcome is often to preserve the task while removing the risky payload.

Sanitisation is also preferable to pure prohibition because many clinical and administrative workflows can benefit from GenAI if the payload is constrained. For example, a draft can often remain useful after identifiers, dates of birth, MRNs, or other direct patient references are removed. The governance question is not whether GenAI can be used at all, but whether the organisation can constrain the input to a safe minimum.

Where the input controls are weak, the problem becomes a data exfiltration issue. Public tools may store prompts, reuse them for product improvement, or expose them through account compromise or integration misuse. That makes NIST Privacy Framework a useful complementary reference for thinking about collection, use, disclosure, and minimisation of sensitive data entering AI systems.

Risk and Threat Considerations

Healthcare prompt misuse creates privacy, compliance, and downstream harm risk because once sensitive patient data leaves the controlled environment, the organisation may lose practical control over retention, sharing, and later exposure. The danger is not only intentional abuse, but routine convenience behaviour that moves PHI into systems the organisation does not govern.

Failure mechanism: staff paste identifiable or clinical content into public genai tools, the content is retained or processed outside approved controls, and the organisation loses visibility into where the data went and who can access it.

Impact: this can trigger privacy incidents, breach response obligations, regulatory scrutiny, and patient trust damage, especially if the same pattern repeats across many users or departments.

Practitioner Guidance

What to prioritise: put controls at the point of submission first, not just in policy documents. If the user can paste patient data into an unapproved tool without friction, the governance model is already failing.

What to verify: confirm that the organisation can distinguish approved from public GenAI tools, detect PHI-like content in prompts, and show what was blocked, redacted, or escalated. If you cannot evidence those three states, you do not yet have operational governance.

Decision rule: if the use case requires patient-specific content, route it only through an approved environment with explicit data handling controls; if it does not require patient-specific content, remove the sensitive material before the prompt is sent. Do not leave the choice to individual judgement alone.

Practitioner takeaway: effective healthcare GenAI governance is less about forbidding AI and more about ensuring that sensitive patient data cannot leave the organisation unnoticed, unredacted, or without an accountable control path.

Related resources from NHI Mgmt Group

• How should organisations train employees to use public AI tools without exposing sensitive data?
• How should healthcare organisations govern non-human identities that handle patient data?
• How should security teams govern employee use of public AI tools in the browser?
• How should banks govern employee use of AI tools with regulated data?